Lilly sees launching weight loss drugs in China, India starting late 2025
by
Contributor since / Followers
Contributor since / Followers
1 month ago
jetcityimage
- Eli Lilly appears (NYSE:LLY) to be accelerating plans to launch its portfolio of weight loss and diabetes drugs to major markets outside the U.S. by the end of the year.
- Comments made earlier Monday by company CFO Lucas Montarce at